NCT05878314 2026-02-10Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast CancerUniversity Hospital TuebingenRecruiting504 enrolled
NCT06705504 2024-11-26A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or AlpelisibNovartisCompleted435 enrolled